Fill out the form and get access to the presentation!
Assay development within the field of AAV therapies; engineering iLite® cell lines for specific and analytical applications
- How can a bioassay be developed for use in the development of AAV therapies?
- What characteristics are important to consider when developing assays for specific therapies?
- Which advantages does the iLite® technology present for gene therapy bioassays?
- How can neutralizing antibodies against AAV vectors be detected using bioassays?
TIME: 14 min
Jordi Rodó, Ph.D., Research Scientist
Svar Life Science AB